Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Research

• Publication date

  2002-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12438234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations of the BRAF gene in human cancer

  2002influential reference
• Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

  2001cited by this paper
• The Raf/MEK/ERK pathway: new concepts of activation

  2001cited by this paper
• Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics.

  2001cited by this paper
• Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

  2000cited by this paper
• Phenotypic and molecular characteristics of hyperplastic polyposis.

  2000cited by this paper
• A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma.

  2000cited by this paper
• Activation of B‐Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601

  2000cited by this paper
• Frequent microsatellite instability and mismatch repair gene mutations in young Chinese patients with colorectal cancer.

  1999cited by this paper
• Colorectal carcinoma in Hong Kong: epidemiology and genetic mutations.

  1997cited by this paper
• High frequency of K-ras mutations in human colorectal hyperplastic polyps.

  1997cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper

• Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening

  2025cites this paper
• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors

  2024cites this paper
• Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico

  2023cites this paper
• BRAF Non-V600 Mutations in Metastatic Colorectal Cancer

  2023cites this paper
• Factors affecting the accuracy of anti-BRAF V600E immunohistochemistry results in ameloblastomas.

  2023cites this paper
• Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy.

  2023cites this paper
• KRAS Mutational Profiles among Colorectal Cancer Patients in the East Coast of Peninsular Malaysia

  2023cites this paper
• Acss2/HIF-2 signaling facilitates colon cancer growth and metastasis

  2023cites this paper
• Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors.

  2022cites this paper
• Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition

  2022cites this paper
• Deep Neural Network for the Prediction of KRAS Genotype in Rectal Cancer.

  2022cites this paper
• EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation

  2022cites this paper
• Expression of Parkin, APC, APE1, and Bcl-xL in Colorectal Polyps

  2021cites this paper
• Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

  2021cites this paper
• Tumour-Derived Cell Lines and Their Potential for Therapy Prediction in Patients with Metastatic Colorectal Cancer

  2021cites this paper
• Genomic Profiling of Small Superficial Non-Ampullary Duodenal Epithelial Tumors

  2021cites this paper
• Genomic profiling of intestinal/mixed‐type superficial non‐ampullary duodenal epithelial tumors

  2021cites this paper
• The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.

  2020cites this paper
• Pulmonary metastasectomy in colorectal carcinoma

  2020cites this paper
• Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis

  2020cites this paper
• DNMT3B Expression Might Contribute to Abnormal Methylation of RASSF1A in Lager Colorectal Adenomatous Polyps

  2020cites this paper
• Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis

  2020cites this paper
• High frequency of microsatellite instability and its substantial co-existence with KRAS and BRAF mutations in Vietnamese patients with colorectal cancer

  2020cites this paper
• CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition

  2019cites this paper
• Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma

  2019cites this paper
• Low dose radiation regulates BRAF-induced thyroid cellular dysfunction and transformation

  2019cites this paper
• Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta-analysis.

  2019cites this paper
• Over expression of METRN predicts poor clinical prognosis in colorectal cancer

  2019influential citation
• MAPK SIGNALLING PATHWAY: ROLE IN CANCER PATHOGENESIS

  2019cites this paper
• Synthesis and In Vitro Biological Evaluation of New Pyrido[2,3‐ b ]pyrazinone‐Based Cytotoxic Agents and Molecular Docking as BRAF Inhibitors

  2019cites this paper
• Somatic mutations in intracranial arteriovenous malformations

  2019cites this paper
• Targeting the RAS-dependent chemoresistance: The Warburg connection.

  2018cites this paper
• Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision Oncology.

  2018cites this paper
• High incidence of BRAF V600 mutation in Indian patients with head and neck cancer.

  2018cites this paper
• Targeting KRAS Mutant CMS3 Subtype by Metabolic Inhibitors.

  2018cites this paper
• How the BRAF V 600 E Mutation Defines a Distinct Subgroup of Colorectal Cancer : Molecular and Clinical Implications

  2018cites this paper
• 17 Understanding Melanocyte Transformation – A Work in Progress

  2018cites this paper
• Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-RafV600E and VEGFR-2.

  2018cites this paper
• DNA mismatch repair in cancer

  2018cites this paper
• Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Carcinoma With Mismatch Repair Deficiency

  2018cites this paper
• How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications

  2018cites this paper
• PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective

  2018cites this paper
• BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report

  2018cites this paper
• KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia

  2017cites this paper
• BRAF mutation in colorectal carcinomas with signet ring cell component

  2017cites this paper
• Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.

  2017cites this paper
• A functional dissection of the relationships between BRAF, DNMT3B and the CpG island methylator phenotype in colorectal cancer

  2017cites this paper
• Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway

  2017cites this paper
• A guanine derivative as a new MEK inhibitor produced by Streptomyces sp. MK63-43F2

  2017cites this paper
• Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survival.

  2017cites this paper
• Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system

  2017cites this paper
• Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders

  2017cites this paper
• Kobe University Repository : Kernel タイトル Tit le BRAF mutat ion associated with dysregulat ion of apoptosis in human colorectal neoplasms

  2017influential citation
• Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma

  2017cites this paper
• Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations

  2017cites this paper
• BRAF mutation is associated with poor clinicopathological outcomes in colorectal cancer: A meta-analysis

  2017cites this paper
• Análisis del riesgo de cáncer colorrectal en pacientes con múltiples pólipos serrados y estudio de marcadores moleculares con implicaciones en su diagnóstico y prevención

  2017cites this paper
• Coexistence of KRAS and BRAF Mutations in Colorectal Cancer: A Case Report Supporting The Concept of Tumoral Heterogeneity

  2017cites this paper
• Predictive Biomarker Testing in Colorectal Cancer : KRAS and BRAF Mutation Frequency and Testing Algorithm in Developing Countries

  2017cites this paper
• Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis

  2016cites this paper
• RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation

  2016cites this paper
• Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci

  2016cites this paper
• Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response

  2016cites this paper
• Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities.

  2016cites this paper
• Analyses of regulatory mechanisms and identification of microRNAs as biomarkers in colorectal cancer

  2016cites this paper
• Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120.

  2016cites this paper
• Mutation Profile of B-Raf Gene Analyzed by fully Automated System and Clinical Features in Japanese Melanoma Patients

  2016cites this paper
• The role of cancer related inflammation, Src family kinases and matrix metalloproteinase 9 in colorectal cancer

  2016cites this paper
• Lack of BRAFV600E mutation in stage I and II of colorectal cancer

  2016cites this paper
• Epigenetic modulation in BRAF mutated metastatic colorectal cancer

  2016cites this paper
• MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers

  2016cites this paper
• Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling

  2016cites this paper
• BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer

  2016cites this paper
• Determination of A Novel Selective B-RafV600E Inhibitor (LXK4) in Dog Plasma by HPLC–MS/MS and its Application in a Pharmacokinetic Study

  2016cites this paper
• The mutations of Kras and BRAF gene in colorectal carcinoma and its clinical significance

  2016cites this paper
• Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions

  2016cites this paper
• Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes

  2015cites this paper
• BRAF in metastatic colorectal cancer: the future starts now.

  2015cites this paper
• Rare Complex Mutational Profile in an ALK Inhibitor-resistant Non-small Cell Lung Cancer.

  2015cites this paper
• Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: association with distinct clinicopathological and molecular features and poor clinical outcome

  2015cites this paper
• Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.

  2015cites this paper
• Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors.

  2015cites this paper
• Colorectal Cancers with the Uncommon Findings of KRAS Mutation and Microsatellite Instability

  2015cites this paper
• Efficacy of organic nanocarriers in a 3D colorectal cancer in vitro model

  2015cites this paper
• Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK

  2015cites this paper
• Low‐concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen‐activated protein kinase pathway activation

  2015cites this paper
• Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers.

  2015cites this paper
• Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene

  2015cites this paper
• Image Analyzer-Based Assessment of Tumor-Infiltrating T Cell Subsets and Their Prognostic Values in Colorectal Carcinomas

  2015cites this paper
• Assessment the Immunohistochemical Expression of Wild BRAF and Mutant BRAFV600E in Iraqi Patients with Colorectal Carcinoma

  2015cites this paper
• Towards functional multiscale analysis of colorectal cancer

  2014cites this paper
• BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential signalling and therapeutic implications

  2014cites this paper
• Establishing a Biological Profile for Interval Colorectal Cancers

  2014cites this paper
• The involvement of microRNAs in autocrine hGH-mediated oncogenesis

  2014cites this paper
• Essential oil of Pinus koraiensis inhibits cell proliferation and migration via inhibition of p21-activated kinase 1 pathway in HCT116 colorectal cancer cells

  2014cites this paper
• Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib.

  2014cites this paper
• Demonstration and biological significance of a gastrin‐P21‐activated kinase 1 feedback loop in colorectal cancer cells

  2014cites this paper
• Intestinal Type of Lung Adenocarcinoma in Younger Adults

  2014cites this paper
• Tracing PAKs from GI inflammation to cancer

  2014cites this paper